• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Promoting platelets is a therapeutic option to combat severe viral infection of the lung.

作者信息

Qiu Jiahuang, Ma Juan, Zhang Shuping, Han Jinxiang, Liu Sijin

机构信息

State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.

University of Chinese Academy of Sciences, Beijing, China; and.

出版信息

Blood Adv. 2020 Apr 28;4(8):1640-1642. doi: 10.1182/bloodadvances.2020001669.

DOI:10.1182/bloodadvances.2020001669
PMID:32315397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7189284/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/7189284/7190acc5520b/advancesADV2020001669f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/7189284/7190acc5520b/advancesADV2020001669f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/7189284/7190acc5520b/advancesADV2020001669f1.jpg

相似文献

1
Promoting platelets is a therapeutic option to combat severe viral infection of the lung.促进血小板生成是对抗严重肺部病毒感染的一种治疗选择。
Blood Adv. 2020 Apr 28;4(8):1640-1642. doi: 10.1182/bloodadvances.2020001669.
2
Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury.流感病毒感染会诱导血小板与内皮细胞黏附，这会导致肺损伤。
J Virol. 2015 Dec 4;90(4):1812-23. doi: 10.1128/JVI.02599-15. Print 2016 Feb 15.
3
Human platelets and their capacity of binding viruses: meaning and challenges?人类血小板及其结合病毒的能力：意义与挑战？
BMC Immunol. 2015 Apr 28;16:26. doi: 10.1186/s12865-015-0092-1.
4
The effect of viral infections on platelets and megakaryocytes.病毒感染对血小板和巨核细胞的影响。
Semin Hematol. 1994 Oct;31(4):329-37.
5
The role of platelets in defence against pathogens.血小板在防御病原体中的作用。
Hamostaseologie. 2011 Nov;31(4):264-8. doi: 10.5482/ha-1152. Epub 2011 Jun 28.
6
Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro.血小板在体外调节针对人呼吸道合胞病毒的固有免疫反应。
Viral Immunol. 2017 Oct;30(8):576-581. doi: 10.1089/vim.2016.0161. Epub 2017 Aug 7.
7
Virus infection and blood coagulation.
Thromb Diath Haemorrh. 1970 Feb 28;23(1):1-11.
8
Transient histiocytosis with striking phagocytosis of platelets, leukocytes, and erythrocytes.伴有显著吞噬血小板、白细胞和红细胞现象的一过性组织细胞增多症。
Arch Intern Med. 1975 Jul;135(7):989-91.
9
Effects of two viral inactivation methods on platelets: laser-UV radiation and merocyanine 540-mediated photoinactivation.两种病毒灭活方法对血小板的影响：激光-紫外线辐射和部花青540介导的光灭活
Blood Cells. 1992;18(1):101-14; discussion 114-6.
10
Viral inactivation of blood components: recent advances.血液成分的病毒灭活：最新进展
Transfus Clin Biol. 1996;3(1):75-7. doi: 10.1016/s1246-7820(96)80015-2.

引用本文的文献

1
An overview for monitoring and prediction of pathogenic microorganisms in the atmosphere.大气中致病微生物的监测与预测概述。
Fundam Res. 2023 Aug 28;4(3):430-441. doi: 10.1016/j.fmre.2023.05.022. eCollection 2024 May.
2
Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis.SARS-CoV-2 刺突 RBD 与血小板因子 4 的相互作用：血栓形成发病机制的新见解。
Int J Mol Sci. 2021 Aug 9;22(16):8562. doi: 10.3390/ijms22168562.
3
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.

本文引用的文献

1
Strategies shift as coronavirus pandemic looms.随着新冠疫情逼近，策略发生转变。
Science. 2020 Feb 28;367(6481):962-963. doi: 10.1126/science.367.6481.962.
2
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
3
Avoid stigmatizing names for 2019 novel coronavirus.避免使用对2019新型冠状病毒带有污名化的名称。
鉴定 FDA 批准的针对 SARS-CoV-2 RNA 依赖性 RNA 聚合酶（RdRp）和 3-糜蛋白酶样蛋白酶（3CLpro）的药物，药物再利用方法。
Biomed Pharmacother. 2021 Jun;138:111544. doi: 10.1016/j.biopha.2021.111544. Epub 2021 Mar 31.
4
The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked?心肌梗死中损伤与保护的血小板悖论——它被忽视了吗？
Basic Res Cardiol. 2021 May 26;116(1):37. doi: 10.1007/s00395-021-00876-6.
5
Proteomics: A Tool to Study Platelet Function.蛋白质组学：研究血小板功能的工具。
Int J Mol Sci. 2021 Apr 30;22(9):4776. doi: 10.3390/ijms22094776.
6
Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.药物重定位方法对抗冠状病毒：潜在药物和药物靶点。
Med Res Rev. 2021 May;41(3):1375-1426. doi: 10.1002/med.21763. Epub 2020 Dec 5.
7
Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study.新型冠状病毒肺炎合并慢性病住院患者的临床特征及预后：一项回顾性单中心研究
J Multidiscip Healthc. 2020 Oct 6;13:1089-1097. doi: 10.2147/JMDH.S273918. eCollection 2020.
8
The Immune Nature of Platelets Revisited.血小板的免疫本质再探。
Transfus Med Rev. 2020 Oct;34(4):209-220. doi: 10.1016/j.tmrv.2020.09.005. Epub 2020 Sep 19.
9
Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19.肝素诱导的血小板减少症（HIT）合并新型冠状病毒肺炎（COVID-19）时出现的结构特征和PF4功能。
Antibodies (Basel). 2020 Oct 10;9(4):52. doi: 10.3390/antib9040052.
10
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）中血小板异质性与宿主免疫反应的观点
Semin Thromb Hemost. 2020 Oct;46(7):826-830. doi: 10.1055/s-0040-1715093. Epub 2020 Sep 3.
Nature. 2020 Feb;578(7795):363. doi: 10.1038/d41586-020-00458-x.
4
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
5
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
6
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.血小板生成素受体激动剂艾曲波帕通过铁螯合抑制人巨细胞病毒复制。
Cells. 2019 Dec 20;9(1):31. doi: 10.3390/cells9010031.
9
HIV and haematopoiesis.HIV 与造血。
S Afr Med J. 2019 Sep 10;109(8b):40-45. doi: 10.7196/SAMJ.2019.v109i8b.13829.
10
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation.依鲁替尼在免疫性血小板减少症、再生障碍性贫血和骨髓增生异常综合征中的作用：从巨核细胞生成到免疫调节。
Drugs. 2019 Aug;79(12):1305-1319. doi: 10.1007/s40265-019-01159-0.